North America Professional Acne Medication Market

1      INTRODUCTION

           1.1      REPORT DESCRIPTION

           1.2      RESEARCH METHODOLOGY

                         1.2.1      SECONDARY RESEARCH

                         1.2.2      DATA ANALYSIS FRAMEWORK

                         1.2.3      MARKET SIZE ESTIMATION

                         1.2.4      FORECASTING

                         1.2.5      PRIMARY RESEARCH AND DATA VALIDATION

2      NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET – EXECUTIVE SUMMARY

           2.1.      MARKET SNAPSHOT, 2023 - 2030, MILLION USD

3      PORTER’S FIVE FORCE MODEL ANALYSIS

           3.1      BARGAINING POWER OF SUPPLIERS

           3.2      BARGAINING POWER OF BUYERS

           3.3      DEGREE OF COMPETITION

           3.4      THREAT OF SUBSTITUTE

           3.5      THREAT OF NEW ENTRANTS

4      MARKET SHARE ANALYSIS

           4.1      MARKET SHARE ANALYSIS OF TOP PROVIDERS, 2023

5      MARKET DYNAMICS

           5.1      GROWTH DRIVERS

                         5.1.1      DRIVER 1

                         5.1.2      DRIVER 2

                         5.1.3      DRIVER 3

                         5.1.4      DRIVER 4

           5.2      CHALLENGES

                         5.2.1      CHALLENGE 1

                         5.2.2      CHALLENGE 2

                         5.2.3      CHALLENGE 3

                         5.2.4      CHALLENGE 4

           5.3      OPPORTUNITIES

                         5.3.1      OPPORTUNITY 1

                         5.3.2      OPPORTUNITY 2

6      NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET BY ACNE TYPE

           6.1      OVERVIEW

           6.2      INFLAMMATORY ACNE

                         6.2.1      INFLAMMATORY ACNE  MARKET, BY COUNTRY

           6.3      NON-INFLAMMATORY ACNE

                         6.3.1      NON-INFLAMMATORY ACNE MARKET, BY COUNTRY

7      NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET BY FORMULATION

           7.1      OVERVIEW

           7.2      TOPICAL MEDICATIONS

                         7.2.1      TOPICAL MEDICATIONS MARKET, BY COUNTRY

           7.3      ORAL MEDICATIONS

                         7.3.1      ORAL MEDICATIONS  MARKET, BY COUNTRY

8      NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET BY THERAPEUTIC CLASS

           8.1      OVERVIEW

           8.2      RETINOIDS

                         8.2.1      RETINOIDS MARKET, BY COUNTRY

           8.3      ANTIBIOTICS

                         8.3.1      ANTIBIOTICS MARKET, BY COUNTRY

           8.4      SALICYLIC ACID

                         8.4.1      SALICYLIC ACID MARKET, BY COUNTRY

           8.5      BENZOYL PEROXIDE

                         8.5.1      BENZOYL PEROXIDE MARKET, BY COUNTRY

           8.6      OTHERS

                         8.6.1      OTHERS MARKET, BY COUNTRY

9      NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET BY DISTRIBUTION CHANNEL

           9.1      OVERVIEW

           9.2      MED SPA

                         9.2.1      MED SPA MARKET, BY COUNTRY

           9.3      AESTHETICIAN

                         9.3.1      AESTHETICIAN MARKET, BY COUNTRY

           9.4      DERMATOLOGIST

                         9.4.1      DERMATOLOGIST MARKET, BY COUNTRY

           9.5      OTHER PROFESSIONAL CHANNELS

                         9.5.1      OTHER PROFESSIONAL CHANNELS MARKET, BY COUNTRY

10   NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET, BY COUNTRY

           10.1   OVERVIEW

           10.2   UNITED STATES

                         10.2.1   NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

                         10.2.2   NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

                         10.2.3   NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

                         10.2.4   NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL

           10.3   CANADA

                         10.3.1   NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

                         10.3.2   NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

                         10.3.3   NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

                         10.3.4   NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL

           10.4   MEXICO

                         10.4.1   NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

                         10.4.2   NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

                         10.4.3   NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

                         10.4.4   NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL

11   COMPANY PROFILES

           11.1   ALMIRALL SA

                         11.1.1   COMPANY OVERVIEW

                         11.1.2   COMPANY SNAPSHOT

                         11.1.3   OPERATING BUSINESS SEGMENTS

                         11.1.4   PRODUCT PORTFOLIO

                         11.1.5   BUSINESS PERFORMANCE

                         11.1.6   BUSINESS SEGMENTS

                         11.1.7   GEOGRAPHIC SEGMENTS

                         11.1.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.1.9   PRIMARY MARKET COMPETITORS

           11.2   BAUSCH HEALTH COMPANIES, INC.

                         11.2.1   COMPANY OVERVIEW

                         11.2.2   COMPANY SNAPSHOT

                         11.2.3   OPERATING BUSINESS SEGMENTS

                         11.2.4   PRODUCT PORTFOLIO

                         11.2.5   BUSINESS PERFORMANCE

                         11.2.6   BUSINESS SEGMENTS

                         11.2.7   GEOGRAPHIC SEGMENTS

                         11.2.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.2.9   PRIMARY MARKET COMPETITORS

           11.3   GLAXOSMITHKLINE PLC (GSK)

                         11.3.1   COMPANY OVERVIEW

                         11.3.2   COMPANY SNAPSHOT

                         11.3.3   OPERATING BUSINESS SEGMENTS

                         11.3.4   PRODUCT PORTFOLIO

                         11.3.5   BUSINESS PERFORMANCE

                         11.3.6   BUSINESS SEGMENTS

                         11.3.7   GEOGRAPHIC SEGMENTS

                         11.3.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.3.9   PRIMARY MARKET COMPETITORS

           11.4   GALDERMA SA

                         11.4.1   COMPANY OVERVIEW

                         11.4.2   COMPANY SNAPSHOT

                         11.4.3   OPERATING BUSINESS SEGMENTS

                         11.4.4   PRODUCT PORTFOLIO

                         11.4.5   BUSINESS PERFORMANCE

                         11.4.6   BUSINESS SEGMENTS

                         11.4.7   GEOGRAPHIC SEGMENTS

                         11.4.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.4.9   PRIMARY MARKET COMPETITORS

           11.5   SUN PHARMACEUTICAL INDUSTRIES LIMITED

                         11.5.1   COMPANY OVERVIEW

                         11.5.2   COMPANY SNAPSHOT

                         11.5.3   OPERATING BUSINESS SEGMENTS

                         11.5.4   PRODUCT PORTFOLIO

                         11.5.5   BUSINESS PERFORMANCE

                         11.5.6   BUSINESS SEGMENTS

                         11.5.7   GEOGRAPHIC SEGMENTS

                         11.5.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.5.9   PRIMARY MARKET COMPETITORS

           11.6   TEVA PHARMACEUTICAL INDUSTRIES LTD.

                         11.6.1   COMPANY OVERVIEW

                         11.6.2   COMPANY SNAPSHOT

                         11.6.3   OPERATING BUSINESS SEGMENTS

                         11.6.4   PRODUCT PORTFOLIO

                         11.6.5   BUSINESS PERFORMANCE

                         11.6.6   BUSINESS SEGMENTS

                         11.6.7   GEOGRAPHIC SEGMENTS

                         11.6.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.6.9   PRIMARY MARKET COMPETITORS

           11.7   JOHNSON AND JOHNSON

                         11.7.1   COMPANY OVERVIEW

                         11.7.2   COMPANY SNAPSHOT

                         11.7.3   OPERATING BUSINESS SEGMENTS

                         11.7.4   PRODUCT PORTFOLIO

                         11.7.5   BUSINESS PERFORMANCE

                         11.7.6   BUSINESS SEGMENTS

                         11.7.7   GEOGRAPHIC SEGMENTS

                         11.7.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.7.9   PRIMARY MARKET COMPETITORS

           11.8   STRATA SKIN SCIENCES, INC.

                         11.8.1   COMPANY OVERVIEW

                         11.8.2   COMPANY SNAPSHOT

                         11.8.3   OPERATING BUSINESS SEGMENTS

                         11.8.4   PRODUCT PORTFOLIO

                         11.8.5   BUSINESS PERFORMANCE

                         11.8.6   BUSINESS SEGMENTS

                         11.8.7   GEOGRAPHIC SEGMENTS

                         11.8.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.8.9   PRIMARY MARKET COMPETITORS

           11.9   MAYNE PHARMA GROUP LIMITED

                         11.9.1   COMPANY OVERVIEW

                         11.9.2   COMPANY SNAPSHOT

                         11.9.3   OPERATING BUSINESS SEGMENTS

                         11.9.4   PRODUCT PORTFOLIO

                         11.9.5   BUSINESS PERFORMANCE

                         11.9.6   BUSINESS SEGMENTS

                         11.9.7   GEOGRAPHIC SEGMENTS

                         11.9.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.9.9   PRIMARY MARKET COMPETITORS

           11.10   PFIZER, INC.

                         11.10.1   COMPANY OVERVIEW

                         11.10.2   COMPANY SNAPSHOT

                         11.10.3   OPERATING BUSINESS SEGMENTS

                         11.10.4   PRODUCT PORTFOLIO

                         11.10.5   BUSINESS PERFORMANCE

                         11.10.6   BUSINESS SEGMENTS

                         11.10.7   GEOGRAPHIC SEGMENTS

                         11.10.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.10.9   PRIMARY MARKET COMPETITORS

LIST OF TABLES

TABLE 1. NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)

TABLE 2. INFLAMMATORY ACNE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 3. NON-INFLAMMATORY ACNE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 4. NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)

TABLE 5. TOPICAL MEDICATIONS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 6. ORAL MEDICATIONS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 7. NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)

TABLE 8. RETINOIDS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 9. ANTIBIOTICS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 10. SALICYLIC ACID, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 11. BENZOYL PEROXIDE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 12. OTHERS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 13. NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)

TABLE 14. MED SPA, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 15. AESTHETICIAN, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 16. DERMATOLOGIST, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 17. OTHER PROFESSIONAL CHANNELS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 18. NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 19. UNITED STATES NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)

TABLE 20. UNITED STATES NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)

TABLE 21. UNITED STATES NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)

TABLE 22. UNITED STATES NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)

TABLE 23. CANADA NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)

TABLE 24. CANADA NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)

TABLE 25. CANADA NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)

TABLE 26. CANADA NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)

TABLE 27. MEXICO NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)

TABLE 28. MEXICO NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)

TABLE 29. MEXICO NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)

TABLE 30. MEXICO NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)

TABLE 31. ALMIRALL S.A.: COMPANY SNAPSHOT

TABLE 32. ALMIRALL S.A.: OPERATING BUSINESS SEGMENTS

TABLE 33. ALMIRALL S.A.: PRODUCT PORTFOLIO

TABLE 34. ALMIRALL S.A.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 35. ALMIRALL S.A.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 36. ALMIRALL S.A.: KEY STRATERGY

TABLE 37. BAUSCH HEALTH COMPANIES, INC.: COMPANY SNAPSHOT

TABLE 38. BAUSCH HEALTH COMPANIES, INC.: OPERATING BUSINESS SEGMENTS

TABLE 39. BAUSCH HEALTH COMPANIES, INC.: PRODUCT PORTFOLIO

TABLE 40. BAUSCH HEALTH COMPANIES, INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 41. BAUSCH HEALTH COMPANIES, INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 42. BAUSCH HEALTH COMPANIES, INC.: KEY STRATERGY

TABLE 43. GLAXOSMITHKLINE PLC (GSK): COMPANY SNAPSHOT

TABLE 44. GLAXOSMITHKLINE PLC (GSK): OPERATING BUSINESS SEGMENTS

TABLE 45. GLAXOSMITHKLINE PLC (GSK): PRODUCT PORTFOLIO

TABLE 46. GLAXOSMITHKLINE PLC (GSK): SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 47. GLAXOSMITHKLINE PLC (GSK): SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 48. GLAXOSMITHKLINE PLC (GSK): KEY STRATERGY

TABLE 49. GALDERMA S.A.: COMPANY SNAPSHOT

TABLE 50. GALDERMA S.A.: OPERATING BUSINESS SEGMENTS

TABLE 51. GALDERMA S.A.: PRODUCT PORTFOLIO

TABLE 52. GALDERMA S.A.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 53. GALDERMA S.A.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 54. GALDERMA S.A.: KEY STRATERGY

TABLE 55. SUN PHARMACEUTICAL INDUSTRIES LIMITED: COMPANY SNAPSHOT

TABLE 56. SUN PHARMACEUTICAL INDUSTRIES LIMITED: OPERATING BUSINESS SEGMENTS

TABLE 57. SUN PHARMACEUTICAL INDUSTRIES LIMITED: PRODUCT PORTFOLIO

TABLE 58. SUN PHARMACEUTICAL INDUSTRIES LIMITED: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 59. SUN PHARMACEUTICAL INDUSTRIES LIMITED: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 60. SUN PHARMACEUTICAL INDUSTRIES LIMITED: KEY STRATERGY

TABLE 61. TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT

TABLE 62. TEVA PHARMACEUTICAL INDUSTRIES LTD.: OPERATING BUSINESS SEGMENTS

TABLE 63. TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCT PORTFOLIO

TABLE 64. TEVA PHARMACEUTICAL INDUSTRIES LTD.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 65. TEVA PHARMACEUTICAL INDUSTRIES LTD.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 66. TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY STRATERGY

TABLE 67. JOHNSON AND JOHNSON: COMPANY SNAPSHOT

TABLE 68. JOHNSON AND JOHNSON: OPERATING BUSINESS SEGMENTS

TABLE 69. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO

TABLE 70. JOHNSON AND JOHNSON: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 71. JOHNSON AND JOHNSON: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 72. JOHNSON AND JOHNSON: KEY STRATERGY

TABLE 73. STRATA SKIN SCIENCES, INC.: COMPANY SNAPSHOT

TABLE 74. STRATA SKIN SCIENCES, INC.: OPERATING BUSINESS SEGMENTS

TABLE 75. STRATA SKIN SCIENCES, INC.: PRODUCT PORTFOLIO

TABLE 76. STRATA SKIN SCIENCES, INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 77. STRATA SKIN SCIENCES, INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 78. STRATA SKIN SCIENCES, INC.: KEY STRATERGY

TABLE 79. MAYNE PHARMA GROUP LIMITED: COMPANY SNAPSHOT

TABLE 80. MAYNE PHARMA GROUP LIMITED: OPERATING BUSINESS SEGMENTS

TABLE 81. MAYNE PHARMA GROUP LIMITED: PRODUCT PORTFOLIO

TABLE 82. MAYNE PHARMA GROUP LIMITED: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 83. MAYNE PHARMA GROUP LIMITED: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 84. MAYNE PHARMA GROUP LIMITED: KEY STRATERGY

TABLE 85. PFIZER, INC.: COMPANY SNAPSHOT

TABLE 86. PFIZER, INC.: OPERATING BUSINESS SEGMENTS

TABLE 87. PFIZER, INC.: PRODUCT PORTFOLIO

TABLE 88. PFIZER, INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 89. PFIZER, INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 90. PFIZER, INC.: KEY STRATERGY

LIST OF FIGURES

FIGURE 1. BARGAINING POWER OF SUPPLIERS

FIGURE 2. BARGAINING POWER OF BUYERS

FIGURE 3. DEGREE OF COMPETITION

FIGURE 4. THREAT OF SUBSTITUTE

FIGURE 5. THREAT OF NEW ENTRANTS

FIGURE 6. NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)

FIGURE 7. INFLAMMATORY ACNE , MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 8. NON-INFLAMMATORY ACNE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 9. NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)

FIGURE 10. TOPICAL MEDICATIONS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 11. ORAL MEDICATIONS , MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 12. NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)

FIGURE 13. RETINOIDS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 14. ANTIBIOTICS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 15. SALICYLIC ACID, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 16. BENZOYL PEROXIDE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 17. OTHERS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 18. NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)

FIGURE 19. MED SPA, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 20. AESTHETICIAN, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 21. DERMATOLOGIST, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 22. OTHER PROFESSIONAL CHANNELS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 23. NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY REGION 2023-2030, (MILLION USD)

FIGURE 24. UNITED STATES NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE 2023-2030, (MILLION USD)

FIGURE 25. UNITED STATES NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION 2023-2030, (MILLION USD)

FIGURE 26. UNITED STATES NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS 2023-2030, (MILLION USD)

FIGURE 27. UNITED STATES NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL 2023-2030, (MILLION USD)

FIGURE 28. CANADA NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE 2023-2030, (MILLION USD)

FIGURE 29. CANADA NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION 2023-2030, (MILLION USD)

FIGURE 30. CANADA NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS 2023-2030, (MILLION USD)

FIGURE 31. CANADA NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL 2023-2030, (MILLION USD)

FIGURE 32. MEXICO NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE 2023-2030, (MILLION USD)

FIGURE 33. MEXICO NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION 2023-2030, (MILLION USD)

FIGURE 34. MEXICO NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS 2023-2030, (MILLION USD)

FIGURE 35. MEXICO NORTH AMERICA PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL 2023-2030, (MILLION USD)

FIGURE 36. ALMIRALL S.A.: NET SALES, (2021-2023)

FIGURE 37. ALMIRALL S.A.: PRIMARY MARKET COMPETITORS

FIGURE 38. BAUSCH HEALTH COMPANIES, INC.: NET SALES, (2021-2023)

FIGURE 39. BAUSCH HEALTH COMPANIES, INC.: PRIMARY MARKET COMPETITORS

FIGURE 40. GLAXOSMITHKLINE PLC (GSK): NET SALES, (2021-2023)

FIGURE 41. GLAXOSMITHKLINE PLC (GSK): PRIMARY MARKET COMPETITORS

FIGURE 42. GALDERMA S.A.: NET SALES, (2021-2023)

FIGURE 43. GALDERMA S.A.: PRIMARY MARKET COMPETITORS

FIGURE 44. SUN PHARMACEUTICAL INDUSTRIES LIMITED: NET SALES, (2021-2023)

FIGURE 45. SUN PHARMACEUTICAL INDUSTRIES LIMITED: PRIMARY MARKET COMPETITORS

FIGURE 46. TEVA PHARMACEUTICAL INDUSTRIES LTD.: NET SALES, (2021-2023)

FIGURE 47. TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRIMARY MARKET COMPETITORS

FIGURE 48. JOHNSON AND JOHNSON: NET SALES, (2021-2023)

FIGURE 49. JOHNSON AND JOHNSON: PRIMARY MARKET COMPETITORS

FIGURE 50. STRATA SKIN SCIENCES, INC.: NET SALES, (2021-2023)

FIGURE 51. STRATA SKIN SCIENCES, INC.: PRIMARY MARKET COMPETITORS

FIGURE 52. MAYNE PHARMA GROUP LIMITED: NET SALES, (2021-2023)

FIGURE 53. MAYNE PHARMA GROUP LIMITED: PRIMARY MARKET COMPETITORS

FIGURE 54. PFIZER, INC.: NET SALES, (2021-2023)

FIGURE 55. PFIZER, INC.: PRIMARY MARKET COMPETITORS

 

At Next Move Strategy Consulting, we understand that insightful market research is the cornerstone of successful business decisions. That's why we employ a robust and multifaceted approach, combining various methodologies to deliver the most accurate and actionable data for our clients.

Research Landscape

We navigate the world of research with two primary approaches:

Qualitative Approach

Our qualitative research methodologies involve immersive techniques such as in-depth interviews, focus groups, and observational studies. By engaging directly with individuals and stakeholders, we uncover valuable insights that quantitative data alone may overlook.

Quantitative Research

In tandem with qualitative methodologies, NMSC leverages the power of Quantitative Research to provide a robust foundation of numerical insights. Through systematic data collection and analysis, we quantify patterns, preferences, and market trends, offering a comprehensive view of the business landscape.

Our quantitative research approach employs diverse tools, including surveys, experiments, and statistical modelling. These methodologies enable us to gather data from a large and representative sample, ensuring the statistical significance of our findings. By employing structured questionnaires and standardized data collection methods, we guarantee the reliability and validity of the information we present to our clients.

Quantitative research is particularly effective in measuring the prevalence of trends, assessing market size, and gauging the impact of various factors on consumer behavior. The numerical precision attained through this approach equips our clients with actionable insights, facilitating data-driven decision-making and strategy formulation.

 

Our Specialized Toolbox for Industry-Specific Market Research

We deploy a specialized arsenal of techniques tailored to meet your unique requirements. Here's a glimpse into our comprehensive toolbox:

Information Procurement

The stage entails acquiring market data or relevant information through various sources and methodologies.

Market Research Approach

We utilize both top-down and bottom-up approaches in market research analysis to achieve a comprehensive understanding of the market dynamics, leveraging the broad perspective of industry trends and macroeconomic factors alongside detailed insights from specific segments and individual companies.

Porters Five Forces Analysis

We conduct Porter's Five Forces analysis to evaluate the competitive landscape of an industry, providing us with insights into factors that affect profitability and strategic positioning.

              

SWOT Analysis

We conduct SWOT analysis to understand market trends, identify potential threats, capitalize on opportunities, and assess our strengths and weaknesses.

Forecasting

We utilize a forecasting model to predict future consumption by considering parameters like population, economics, regulations, market competition, drivers, constraints, technology, and pricing. We also employ statistical techniques such as multilinear regression, exponential smoothing, moving average, ARIMA, and Monte Carlo simulations for accurate predictions. In econometric forecasting, we analyzed short-term and long-term event impacts, attributing values based on regulatory frameworks, economic factors, and market events.